BackgroundCheck.run
Search For

Ronald B Luftig, 855120 Pike Dr, Metairie, LA 70003

Known as:
Ron B Luftig Ronald B Rupdi Ronald B Lufti Ronald B Lutfi Ronald B Luffig Ronald Addison Ronald G Ronald C
Related to:
Nikoma Thompson

Ronald Luftig Phones & Addresses

5120 Pike Dr, Metairie, LA 70003    504-3042224    504-8891335   

4353 Country Hill Dr, Baton Rouge, LA 70816    225-7568766   

Gretna, LA   

5120 Pike Dr, Metairie, LA 70003   

Social networks

Ronald B Luftig

Linkedin

Work

Company: Lsu health sciences center 2010 to 2014 Position: Professor emeritus

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Chicago 1962 to 1967 Specialities: Biophysics, Philosophy

Skills

Teaching • Higher Education • Medical Education • Science • Medical Research

Industries

Hospital & Health Care
Get Report
Control this profile

Mentions for Ronald B Luftig

Ronald Luftig resumes & CV records

Resumes

Ronald Luftig Photo 2

Ronald Luftig

Location:
Metairie, LA
Industry:
Hospital & Health Care
Work:
Lsu Health Sciences Center 2010 - 2014
Professor Emeritus University of South Carolina 1979 - 1983
Full Professor Worcester Foundation For Experimental Biology 1973 - 1979
Senior Scientist Duke University Medical Center Sep 1969 - Jul 1973
Assistant Professor
Education:
University of Chicago 1962 - 1967
Doctorates, Doctor of Philosophy, Biophysics, Philosophy New York University 1960 - 1962
Master of Science, Masters, Mathematics
Skills:
Teaching, Higher Education, Medical Education, Science, Medical Research

Publications & IP owners

Us Patents

Non-Infectious, Protease Defective Hiv Particles And Nucleic Acid Molecules Encoding Therefor

US Patent:
6557296, May 6, 2003
Filed:
Jul 30, 2001
Appl. No.:
09/919124
Inventors:
Ronald B. Luftig - Metairie LA
Assignee:
The Immune Response Corporation - Carlsbad CA
International Classification:
C12N 506
US Classification:
45339, 435 5, 435 71, 435 39, 435 697, 536 2372, 530324, 53038835, 5303894
Abstract:
This invention is directed toward mutated DNA, proteins, or protein fragments and particles from the L-2 cell line. The invention is also directed to diagnostic, prophylactic and therapeutic methods of making and using the DNA, proteins and particles.

Non-Infectious, Protease Defective Hiv Particles And Nucleic Acid Molecules Encoding Therefor

US Patent:
6328976, Dec 11, 2001
Filed:
Apr 3, 1998
Appl. No.:
9/055075
Inventors:
Ronald B. Luftig - Metairie LA
Assignee:
Immune Response Corporation - Carlsbad CA
International Classification:
A61K 3921
A61K 3800
A61K 3804
US Classification:
4242081
Abstract:
This invention is directed toward mutated DNA, proteins, or protein fragments and particles from the L-2 cell line. The invention is also directed to diagnostic, prophylactic and therapeutic methods of making and using the DNA, proteins and particles.

Detection Of Human Adenovirus

US Patent:
5106965, Apr 21, 1992
Filed:
Apr 9, 1990
Appl. No.:
7/507421
Inventors:
Norman J. Pieniazek - Suwanee GA
Susan B. Slemenda - Decatur GA
Danuta Pieniazek - Suwanee GA
Jorge Velarde - San Diego CA
Ronald B. Luftig - Metairie LA
Assignee:
Research Corporation Technologies, Inc. - Tucson AZ
International Classification:
C12Q 170
C07K 300
US Classification:
536 27
Abstract:
The present invention relates to DNA and proteins of human adenovirus Type 41 and their use in detection of said virus. More specifically, the present invention relates to the isolation of a 41. 4 kd short fiber protein and a 60. 6 kd long fiber protein of adenovirus type 41 (Ad41), as well as proteins derived from the Ad41 E3 region, thereby providing virus-derived antigens and active derivatives and parts thereof, useful in the development of diagnostic assays, DNA probes and vaccines for said virus or other related viruses belonging to the human enteric adenovirus family. In addition, the present invention is directed to recombinant DNA molecules containing the human enteric adenovirus Type 41 Tak long fiber protein gene, the Ad41 short fiber protein gene and the Ad41 E3 gene (encoding the Ad41 proteins RL-1 to RL-6) thereby providing a source of recombinant viral components useful in the development of said diagnostic assays, DNA probes and vaccines for human adenoviruses. The present invention is also directed to first antibodies specific to the above-identified Ad41 viral components and to second antibodies specific to the first antibodies. These second antibodies are also useful in the development of diagnostic assays for Ad41 and other adenoviruses.

Isbn (Books And Publications)

Microbiology And Immunology

Author:
Ronald B. Luftig
ISBN #:
0397515472

Possible Relatives

Lisa J Luftig  Mark D Luftig  Stacey F Luftig  Ronald W Johnson  Ronald R Stamps  Ronald L Stancill  Ronald W Standen  Ronald G Johnston  Ronald T Stanek  Ronald W Stanfield 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.